February 2023 in “Indian Journal of Postgraduate Dermatology” The IADVL offers residents grants, scholarships, training, and learning resources for academic growth.
May 1995 in “Hair transplant forum international” The document's conclusion cannot be summarized because the content is not accessible or understandable.
January 2026 in “Journal of Clinical and Investigative Dermatology” Verilich serum effectively and safely improves hair loss treatment.
March 2010 in “Hair transplant forum international” The document's conclusion cannot be provided because the document is not readable.
September 2025 in “Journal of the American Academy of Dermatology” Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.
5 citations
,
July 2023 in “International Journal of Women’s Dermatology” Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.
39 citations
,
August 2022 in “Pharmaceutics” Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.
July 2023 in “Journal of exploratory research in pharmacology” A new psoriasis lotion called "Psorisbye" improved symptoms in a patient within one week.
6 citations
,
December 2015 in “Medwave” Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.
February 1842 in “Annals of clinical and laboratory science”
November 2021 in “World Family Medicine Journal /Middle East Journal of Family Medicine” Inclisiran is effective at lowering cholesterol.
April 2026 in “International Journal of Clinical Case Reports and Reviews” A new non-invasive laser system improves chronic disease management and metabolic health.
The new gel effectively treats psoriasis with minimal side effects.
May 2023 in “Journal of Drugs in Dermatology” REVIVV® serum improves hair growth and reduces shedding in androgenetic alopecia.
July 2012 in “Hair transplant forum international” The document's conclusion cannot be summarized because the content is not accessible.
January 2015 in “Hair transplant forum international” The document's conclusion cannot be summarized because the content is not accessible.
November 2013 in “Hair transplant forum international” The document's conclusion cannot be summarized because the content is not accessible.
March 2011 in “Hair transplant forum international” The document's conclusion cannot be summarized because the content is not accessible.
October 2024 in “International Journal For Multidisciplinary Research” Wedelolactone may help treat chronic diseases due to its strong antioxidant properties.
April 2026 in “Clinical and Experimental Dermatology” Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.
December 2025 in “Journal of Integrated Standardized Homoeopathy” A woman with hypothyroidism stopped taking levothyroxine after successful homeopathic treatment.
5 citations
,
December 2023 in “Current Biology” A feedback loop between LRH and RSL4 controls root hair growth in Arabidopsis.
84 citations
,
August 2023 in “Drugs” Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.
2 citations
,
July 1996 in “Hair transplant forum international” The document's conclusion cannot be provided because the document is not accessible or understandable.
November 2024 in “Open Repository of the University of Porto (University of Porto)” Tailored medication preparation and ongoing education are crucial for effective treatments.
October 2023 in “IP Indian Journal of Clinical and Experimental Dermatology” The luliconazole shampoo effectively reduces symptoms of seborrheic dermatitis and is well-tolerated.
1 citations
,
May 2025 in “The Journal of Rheumatology” Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.
July 2026 in “Journal of Investigative Dermatology”
October 2024 in “Open Repository of the University of Porto (University of Porto)” Pharmacists play a crucial role in personalized care and medication management.
1 citations
,
November 2025 in “International Journal of Clinical Pharmacy” Cladribine has known risks and potential new safety concerns, requiring careful monitoring.